You are currently visiting a Non-US site. 
US visitors please click here >
ossix bone

OSSIX™ Bone

 

Datum Dental's newly developed dental bone grafting material OSSIX™ Bone, is a resorbable sponge-like matrix of hydroxyapatite and collagen cross-linked by sugar.

Developed to augment hard tissue in periodontal and implant surgeries, it also utilizes GLYMATRIX® technology featured in OSSIX® PLUS and OSSIX®  VOLUMAX. 

OSSIX™ Bone is cleared by the FDA for marketing in the USA 510(k). OSSIX ™ Bone is pending CE Mark. 
 
OSSIX Bone product photo
Alveolar Ridge Restoration Using a New Sugar Cross-linked Collagen-Hydroxyapatite Matrix in Canine L-shape Defects was presented in the E-Poster Session at the AO Academy of Osseointegration 2017 Annual Meeting held March 2017, in Orlando, Florida, USA. 



  • Healing and biocompatibility profiles of OSSIX™ Bone treated defects were equivalent to those treated with Bio-Oss® Collagen.
  • OSSIX™ Bone outperformed the empty control demonstrating statistically improved bone growth and ridge restoration (height and width) at 24 Weeks.
  • OSSIX™ Bone sites showed significantly larger overall ridge restoration and ridge widths compared to Bio-Oss® Collagen.
  • Additionally, OSSIX™ Bone maintained its cohesive integrity within the site (no migration) as opposed to Bio-Oss® Collagen, in which migration was seen in 12 out of 19 animals.

OSSIX™ Bone is available in 3 sizes. 
  • 5x5x5 mm (0.125cc) bone grafting material 
  • 5x5x10 mm  (0.25 cc) bone grafting material
  • 5x10x10 mm  (0.5 cc) bone grafting material 

OSSIX™ Bone is available in the USA from OraPharma. OSSIX™ Bone is CE Marking pending. 
 
Please contact us if you would like to be updated when OSSIX™ Bone becomes available in your country.



WHO WE ARE

Datum Dental Ltd is a subsidiary company of Datum Biotech. The Company was created in order to develop, manufacture and market a full line of dental biomaterials for tissue and bone regeneration.

Datum Biotech Ltd is an Israeli based Biomaterials company that specializes in developing, manufacturing and commercializing proprietary technologies, which are based on innovative and unique sugar cross-linked collagen products for tissue engineering and regenerative medicine.
read more